Gastroenteritis
- 2020/07 - Recommendations (Pdf, 725 Kb) on rotavirus gastroenteritis vaccination of infants
The universal gastroenteritis vaccination programme for infants is to be continued. Vaccination may be with either of the two products below, depending on availability: - RotaTeq® (a pentavalent vaccine): three doses administered orally, at the ages of two, three and four months, with the last dose being administered at 32 weeks at the latest; - Rotarix® (a monovalent vaccine): two doses administered orally, at the ages of two and four months, with the last dose being administered at 24 weeks at the latest. Either of these oral vaccines may be administered at the same time as the other vaccines administered as part of the universal vaccination schedule. - 2019/12 - Recommendations (Pdf, 778 Kb) on the vaccination of babies born prematurely
The Superior Council of Infectious Diseases (Conseil supérieur des maladies infectieuses - CSMI) recommends vaccinating babies born prematurely (i.e. before 37 weeks of amenorrhoea) as follows: 1) depending on the child's age 2) by supplementing the universal vaccination schedule with an additional dose: 2.1.) of pneumococcal conjugate vaccine (3+1 schedule, at 8, 12, 16 weeks, then at one year), for premature babies < 33 weeks, or <1,500 g; 2.2.) of hepatitis B vaccine (3+1 schedule, at 8, 12, 16 weeks, then at one year), for premature babies <2,000 g; 3) by supplementing the universal vaccination schedule with: 3.1.) a seasonal influenza vaccine dose, for premature babies <33 weeks, for the first two winter seasons; 3.2.) RSV (respiratory syncytial virus) immunisation, for premature babies who are at risk during the winter season. In addition, the CSMI recommends checking and updating the vaccination status of those in the premature baby's family circle – especially as regards whooping cough – and vaccinating them against seasonal influenza during the child's first two winters.
Last update